background
studi
aim
character
epidemiolog
pathogen
respiratori
agent
patient
age
month
hospit
acut
respiratori
infect
tunisia
method
total
pathogen
includ
virus
mycoplasma
pneumonia
streptococcu
pneumonia
detect
use
molecular
sensit
assay
associ
patient
demograph
data
season
analyz
result
viral
infecti
agent
found
specimen
dual
multipl
infecti
agent
detect
sampl
respect
viral
infect
predomin
pediatr
environ
p
male
patient
spring
rhinoviru
detect
viru
follow
respiratori
syncyti
viru
ab
coronaviru
group
adenoviru
parainfluenza
virus
respiratori
syncyti
viru
ab
significantli
associ
gender
male
case
vs
femal
case
p
infect
adenoviru
bocaviru
metapneumoviru
ab
increas
increas
age
patient
predomin
case
age
month
p
pneumonia
detect
th
test
sampl
neg
viral
infect
pneumonia
identifi
conclus
predomin
rhinoviru
infect
observ
studi
coronaviru
subtyp
describ
first
time
tunisia
observ
differ
pathogen
profil
across
age
group
could
help
avoid
misclassif
patient
present
ari
triag
level
standard
protocol
avail
studi
provid
clue
physician
inform
decis
regard
prevent
strategi
medic
tunisia
demographi
infant
molecular
assay
neonat
respiratori
agent
season
open
access
articl
term
creativ
common
attribut
licens
permit
use
distribut
reproduct
medium
provid
origin
work
properli
cite
addit
support
inform
may
found
onlin
support
inform
section
end
articl
cite
articl
brini
khalifa
hannachi
n
guerrero
et
al
demograph
season
characterist
respiratori
pathogen
neonat
infant
age
month
centraleast
region
tunisia
j
med
virol
world
health
organ
estim
acut
respiratori
infect
ari
second
lead
caus
childhood
death
infect
occur
africa
southeast
asia
ari
respons
children
hospit
cours
infect
sever
children
age
less
year
ari
caus
varieti
pathogen
infecti
agent
includ
virus
bacteria
fungi
virus
predomin
virus
associ
ari
classifi
old
respiratori
virus
novel
respiratori
virus
old
fungal
ari
children
rare
found
mainli
immunocompromis
patient
acquisit
spread
ari
vari
among
studi
popul
differ
countri
may
due
children
malnutrit
low
socioeconom
statu
countri
cultur
habit
commun
patient
immun
defici
localregion
geograph
climat
chang
variabl
health
care
system
public
privat
hospit
consequ
morbid
relat
ari
mostli
observ
develop
world
hand
expand
number
pathogen
identifi
caus
agent
ari
might
due
introduct
molecular
techniqu
multiplex
realtim
polymeras
chain
reaction
qpcr
qrtpcr
routin
assay
increas
sensit
specif
detect
allow
identif
wide
rang
virus
bacteria
one
reaction
help
better
understand
pathogenesi
ari
howev
develop
countri
applic
multiplex
assay
fulli
implic
routin
laboratori
test
due
high
cost
far
arab
maghreb
concern
laboratori
perform
mostli
enzym
immunoassay
rapid
diagnost
test
latex
agglutin
techniqu
frequent
pathogen
routin
test
use
qpcr
assay
gener
avail
owe
absenc
detail
diagnost
test
infect
manag
empir
antibiot
regimen
result
overus
broadspectrum
antibiot
favor
develop
bacteria
bacteri
resist
tunisia
studi
etiolog
larg
rang
respiratori
microb
across
season
among
variou
age
gendersand
applic
molecular
sensit
assaysar
limit
tunisian
studi
publish
el
moussi
et
al
report
distribut
common
respiratori
virus
use
multiplex
assay
howev
associ
viral
infect
sociodemograph
situat
patient
season
distribut
detect
pathogen
observ
studi
addit
bacteri
identif
exclud
light
present
studi
total
virus
associ
ari
analyz
use
sensit
multiplex
molecular
assay
addit
detect
bacteri
genom
pneumonia
pneumonia
perform
moreov
demograph
characterist
detect
pathogen
well
season
analyz
studi
aim
gain
better
understand
epidemiolog
common
respiratori
microb
area
souss
tunisia
find
help
reduc
use
unnecessari
antibiot
thu
avoid
bacteri
resist
contribut
implement
prevent
control
system
tunisia
present
studi
approv
formal
author
scientif
ethic
committe
farhat
hach
universityhospit
fhuh
souss
tunisia
approv
number
irb
provid
ohrp
total
subject
age
month
hospit
upper
andor
lower
ari
pediatr
pp
neonatolog
nn
ward
fhuh
souss
tunisia
enrol
demograph
data
includ
age
ward
admiss
date
hospit
season
gender
obtain
use
fullfil
inform
form
studi
popul
divid
three
age
group
first
group
includ
neonat
age
day
second
third
group
contain
infant
group
infant
describ
follow
group
character
patient
age
day
month
third
group
compris
subject
age
month
tabl
statist
calcul
evalu
use
statist
packag
distribut
pathogen
infecti
agent
includ
virus
pneumonia
age
gender
describ
tabl
support
inform
tabl
within
subject
test
viral
infect
singl
posit
doubl
infect
multipl
infect
detect
virus
per
sampl
among
neg
viral
infect
pneumonia
singl
detect
pathogen
tabl
possibl
associ
singledoublemultipl
viral
infect
demograph
characterist
season
distribut
well
individu
viral
infect
describ
tabl
male
patient
frequent
detect
within
multipl
infect
multipl
infect
infect
femal
subject
found
singl
infect
categori
julsep
variabl
season
left
blank
valu
zero
obtain
describ
refer
group
use
statist
calcul
p
valu
calcul
use
x
test
fisher
exact
test
spss
valu
p
consid
signific
repres
bold
brini
khalifa
et
al
multiplex
qrtpcr
detect
high
rate
viral
infect
estim
compar
studi
shown
variabl
detect
rate
rang
less
wide
differ
observ
detect
rate
infecti
pathogen
agent
could
interpret
heterogen
studi
popul
genet
variabl
popul
natur
biolog
materi
use
detect
respiratori
pathogen
multiplex
assay
techniqu
climateregion
factor
influenc
appear
respiratori
agent
studi
rv
rsv
ab
frequent
detect
virus
found
test
specimen
respect
known
crucial
caus
ari
children
addit
male
predomin
observ
within
mpv
ab
follow
bov
indic
infect
rate
infect
bov
recent
attract
attent
worldwid
incid
respiratori
infect
pathogen
vari
wide
often
involv
comultipl
infect
potenti
pathogen
agreement
present
studi
member
picornavirida
famili
pev
ev
screen
although
pev
frequent
isol
patient
respiratori
infect
thought
associ
diseas
qrtpcr
shown
best
way
detect
ev
pev
still
littl
known
prognosi
virus
summari
high
preval
etiolog
associ
respiratori
infect
relev
pathogen
highlight
import
sustain
nation
surveil
ari
clearli
estim
role
associ
pathogen
establish
burden
diseas
find
studi
address
sever
import
gap
literatur
tunisia
cov
subtyp
describ
first
time
tunisia
reveal
frequent
detect
spite
common
knowledg
rsv
ab
common
respiratori
agent
respons
ari
rv
found
preval
popul
highlight
interest
cost
benefit
studi
concern
implement
routin
laboratori
test
given
multipl
find
studi
provid
use
start
point
better
understand
circul
pathogen
area
souss
season
demograph
attribut
viralbacteri
infect
contribut
data
relev
develop
prevent
strategi
help
clinic
decis
allow
consid
antivir
therapi
clinic
routin
avail
vaccin
tunisia
infv
infect
afford
ongo
vaccin
research
develop
mani
lead
viral
pathogen
futur
